Aplastic Anaemia and Other Bone Marrow Failure Syndromes Registry (AAR)
Monash University
1,000 participants
Jun 28, 2013
Observational
Conditions
Summary
Aplastic Anaemia (AA) and Bone Marrow Failure Syndromes (BMFS) are rare diseases with significant morbidity and mortality. Currently there is little Australian data on the incidence of both acquired AA and BMFS, the therapies utilised or clinical outcomes. The relative rarity of this disease makes both the accrual of data and material to support scientific studies, and the establishment of high quality randomised prospective trials challenging. Furthermore, the existing literature concerning clinical outcomes of patients with AA may be biased by preferential reporting and publication of only good outcomes and/or serious or unusual events. The national registry for all Australian patients with AA and BMFS provides an important community resource to address these issues.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This is a clinical registry collecting information on adult and paediatric patients with a diagnosis of aplastic anaemia or any other acquired or inherited bone marrow failure syndrome. Data to be collected includes, but is not limited to: demographics, family history, co-morbidities, clinical features, full blood examination, bone marrow assessments, diagnosis, treatment received, treatment outcomes and overall survival. Information will be collected by review of medical records. Patients are not required to complete any questionnaires.
Locations(37)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12623000461695